These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 16855632

  • 1. Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias.
    Malempati S, Tibbitts D, Cunningham M, Akkari Y, Olson S, Fan G, Sears RC.
    Leukemia; 2006 Sep; 20(9):1572-81. PubMed ID: 16855632
    [Abstract] [Full Text] [Related]

  • 2. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
    Bubman D, Guasparri I, Cesarman E.
    Oncogene; 2007 Jul 26; 26(34):4979-86. PubMed ID: 17310999
    [Abstract] [Full Text] [Related]

  • 3. The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.
    Liu J, Martin HJ, Liao G, Hayward SD.
    J Virol; 2007 Oct 26; 81(19):10451-9. PubMed ID: 17634226
    [Abstract] [Full Text] [Related]

  • 4. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.
    Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR.
    Genes Dev; 2000 Oct 01; 14(19):2501-14. PubMed ID: 11018017
    [Abstract] [Full Text] [Related]

  • 5. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C, Blivet-Van Eggelpoël MJ, Beurel E, Boissan M, Delélo R, Cadoret A, Capeau J.
    Hepatology; 2002 Dec 01; 36(6):1528-36. PubMed ID: 12447879
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt.
    Chen YC, Su YN, Chou PC, Chiang WC, Chang MC, Wang LS, Teng SC, Wu KJ.
    J Biol Chem; 2005 Sep 16; 280(37):32505-11. PubMed ID: 16036916
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc.
    Arnold HK, Zhang X, Daniel CJ, Tibbitts D, Escamilla-Powers J, Farrell A, Tokarz S, Morgan C, Sears RC.
    EMBO J; 2009 Mar 04; 28(5):500-12. PubMed ID: 19131971
    [Abstract] [Full Text] [Related]

  • 9. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis.
    Huang HL, Weng HY, Wang LQ, Yu CH, Huang QJ, Zhao PP, Wen JZ, Zhou H, Qu LH.
    Mol Cancer Ther; 2012 May 04; 11(5):1155-65. PubMed ID: 22389469
    [Abstract] [Full Text] [Related]

  • 10. Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells.
    Inoue C, Sobue S, Kawamoto Y, Nishizawa Y, Ichihara M, Abe A, Hayakawa F, Suzuki M, Nozawa Y, Murate T.
    Biochem Biophys Res Commun; 2020 May 14; 525(4):1074-1080. PubMed ID: 32184020
    [Abstract] [Full Text] [Related]

  • 11. DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein.
    An J, Yang DY, Xu QZ, Zhang SM, Huo YY, Shang ZF, Wang Y, Wu DC, Zhou PK.
    Mol Cancer; 2008 Apr 22; 7():32. PubMed ID: 18426604
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of c-myc degradation by nickel compounds and hypoxia.
    Li Q, Kluz T, Sun H, Costa M.
    PLoS One; 2009 Dec 31; 4(12):e8531. PubMed ID: 20046830
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T-cell acute lymphoblastic leukemia.
    Yu H, Yin Y, Yi Y, Cheng Z, Kuang W, Li R, Zhong H, Cui Y, Yuan L, Gong F, Wang Z, Li H, Peng H, Zhang G.
    Cancer Commun (Lond); 2020 Oct 31; 40(10):501-517. PubMed ID: 32820611
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo.
    Parisi F, Riccardo S, Daniel M, Saqcena M, Kundu N, Pession A, Grifoni D, Stocker H, Tabak E, Bellosta P.
    BMC Biol; 2011 Sep 27; 9():65. PubMed ID: 21951762
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
    Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman BE.
    Proc Natl Acad Sci U S A; 2004 Jun 15; 101(24):9085-90. PubMed ID: 15150404
    [Abstract] [Full Text] [Related]

  • 20. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens.
    Kamemura K, Hayes BK, Comer FI, Hart GW.
    J Biol Chem; 2002 May 24; 277(21):19229-35. PubMed ID: 11904304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.